BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...

Medical technology company BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced the adoption of Ethereum (CRYPTO: ETH) as ...

The tech firm will prioritize Ethereum over Bitcoin as a strategic asset, touting the asset's potential as a "financial ...

Ethereum has been chosen over Bitcoin as a medical firm's treasury asset. The firm cited staking, DeFi, dApps, and other ...

BioNexus Gene Lab board of directors has officially approved the Ethereum-focused treasury strategy, alongside an ETH ...

BioNexus Gene Lab Corporation, a leading medical laboratory services provider, has made history by becoming the first ...

Additionally, BioNexus sees Ethereum’s deep integration in the global financial ecosystem as a key factor. The Ethereum ...

BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership with ML Tech to optimize the BGLC’s ...

Medical technology company BioNexus Gene Lab Corp. BGLC announced the adoption of Ethereum ETH/USD as a treasury reserve asset on Wednesday, following the cryptocurrency’s inclusion in the U.S ...